What is Leerink Partnrs’ Estimate for BPMC FY2025 Earnings?
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Leerink Partnrs dropped their FY2025 earnings per share (EPS) estimates for Blueprint Medicines in a note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of ($1.24) for the year, down from their […]
Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) – Leerink Partnrs dropped their FY2025 earnings per share (EPS) estimates for Blueprint Medicines in a note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens now forecasts that the biotechnology company will post earnings per share of ($1.24) for the year, down from their […]
